Anti‐angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives

@article{Rath2012AntiangiogenicEO,
  title={Anti‐angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives},
  author={S. Rath and J. Liebl and R. F{\"u}rst and A. Ullrich and J. L. Burkhart and U. Kazmaier and J. Herrmann and R. M{\"u}ller and M. G{\"u}nther and L. Schreiner and E. Wagner and A. Vollmar and S. Zahler},
  journal={British Journal of Pharmacology},
  year={2012},
  volume={167}
}
BACKGROUND AND PURPOSE The use of tubulin‐binding compounds, which act in part by inhibiting tumour angiogenesis, has become an integral strategy of tumour therapy. Recently, tubulysins were identified as a novel class of natural compounds of myxobacterial origin, which inhibit tubulin polymerization. As these compounds are structurally highly complex, the search for simplified precursors [e.g. pretubulysin (Prt)] and their derivatives is mandatory to overcome supply problems hampering clinical… Expand
Simplified pretubulysin derivatives and their biological effects on cancer cells.
Pretubulysin: a new option for the treatment of metastatic cancer
Novel Tubulin Antagonist Pretubulysin Displays Antivascular Properties In Vitro and In Vivo
Synthetic Approaches Towards Tubulysins and Derivatives Thereof
Total Synthesis and Biological Evaluation of Natural and Designed Tubulysins.
Total Synthesis and Biological Evaluation of Tubulysin Analogues.
Anti‐angiogenic effects of novel cyclin‐dependent kinase inhibitors with a pyrazolo[4,3‐d]pyrimidine scaffold
...
1
2
3
4
...

References

SHOWING 1-10 OF 30 REFERENCES
Synthesis and Biological Evaluation of Pretubulysin and Derivatives
Biological evaluation of tubulysin A: a potential anticancer and antiangiogenic natural product.
Mechanism of Action of Tubulysin, an Antimitotic Peptide from Myxobacteria
Pretubulysin, a potent and chemically accessible tubulysin precursor from Angiococcus disciformis.
Investigation of the marine compound spongistatin 1 links the inhibition of PKCα translocation to nonmitotic effects of tubulin antagonism in angiogenesis
  • A. Rothmeier, I. Ischenko, +5 authors S. Zahler
  • Biology, Medicine
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
  • 2009
Tubulin-interactive natural products as anticancer agents.
  • D. Kingston
  • Chemistry, Medicine
  • Journal of natural products
  • 2009
Polymeric Tubulysin-Peptide Nanoparticles with Potent Antitumor Activity
The anti-angiogenic basis of metronomic chemotherapy
Syntheses and Evaluation of Simplified Pretubulysin Analogues
...
1
2
3
...